339 related articles for article (PubMed ID: 16701094)
21. Sentinel lymph node detection in patients with early-stage breast cancer: comparison of periareolar and subdermal/peritumoral injection techniques.
Pelosi E; Bellò M; Giors M; Ala A; Giani R; Bussone R; Bisi G
J Nucl Med; 2004 Feb; 45(2):220-5. PubMed ID: 14960639
[TBL] [Abstract][Full Text] [Related]
22. Sentinel node localization in breast cancer using intradermal dye injection: results, influencing factors and learning curve.
Ratanachaikanont T; Karalak A
J Med Assoc Thai; 2005 Mar; 88(3):386-90. PubMed ID: 15962649
[TBL] [Abstract][Full Text] [Related]
23. A concordance study of subareolar and subdermal injections for breast cancer sentinel lymph node mapping.
Gray RJ; Pockaj BA
Am J Surg; 2004 Oct; 188(4):423-5. PubMed ID: 15474440
[TBL] [Abstract][Full Text] [Related]
24. [Sentinel lymph node detection in patients with early-stage breast cancer: which site of injection in 2011?].
Frati A; Delpech Y; Bricou A; Barranger E
Gynecol Obstet Fertil; 2011 Nov; 39(11):620-3. PubMed ID: 21873098
[TBL] [Abstract][Full Text] [Related]
25. Isolated retromammary lymph node metastasis of breast cancer without axillary lymph node involvement: a case report with a false-negative sentinel lymph node biopsy.
Rokutanda N; Horiguchi J; Koibuchi Y; Nagaoka R; Sato A; Odawara H; Tokiniwa H; Iino Y; Hirato J; Takeyoshi I
Breast Cancer; 2009; 16(2):162-5. PubMed ID: 19242778
[TBL] [Abstract][Full Text] [Related]
26. Sentinel node mapping for breast cancer: the operative experience of a breast surgeon in a rural community.
Davit FE; Gatmaitan P; Garguilo G
Am Surg; 2008 May; 74(5):423-7. PubMed ID: 18481500
[TBL] [Abstract][Full Text] [Related]
27. [Validation of sentinel node in breast cancer].
Vergara-Fernández O; Cortés-González R; Medina-Franco H
Rev Invest Clin; 2004; 56(3):309-13. PubMed ID: 15612512
[TBL] [Abstract][Full Text] [Related]
28. Lymphatic mapping and sentinel node biopsy in gastric cancer.
Song X; Wang L; Chen W; Pan T; Zhu H; Xu J; Jin M; Finley RK; Wu J
Am J Surg; 2004 Feb; 187(2):270-3. PubMed ID: 14769318
[TBL] [Abstract][Full Text] [Related]
29. Value of the sentinel lymph node procedure in patients with large size breast cancer.
Lelievre L; Houvenaeghel G; Buttarelli M; Brenot-Rossi I; Huiart L; Tallet A; Tarpin C; Jacquemier J
Ann Surg Oncol; 2007 Feb; 14(2):621-6. PubMed ID: 17103062
[TBL] [Abstract][Full Text] [Related]
30. Is there any benefit from sentinel lymph node biopsy using the combined radioisotope/dye technique in breast cancer patients with clinically negative axilla?
Koukouraki S; Sanidas E; Askoxilakis J; Stathaki M; Charalambakis V; Daboudi M; Voutoufianaki I; Kafousi M; Stathopoulos E; Tsiftsis D; Karkavitsas N
Nucl Med Commun; 2009 Jan; 30(1):48-53. PubMed ID: 19020472
[TBL] [Abstract][Full Text] [Related]
31. Comparison of blue dye and isotope with blue dye alone in breast sentinel node biopsy.
Syme DB; Collins JP; Mann GB
ANZ J Surg; 2005 Sep; 75(9):817-21. PubMed ID: 16174001
[TBL] [Abstract][Full Text] [Related]
32. Sentinel lymph node biopsy after neoadjuvant chemotherapy is accurate in breast cancer patients with a clinically negative axillary nodal status at presentation.
Gimbergues P; Abrial C; Durando X; Le Bouedec G; Cachin F; Penault-Llorca F; Mouret-Reynier MA; Kwiatkowski F; Maublant J; Tchirkov A; Dauplat J
Ann Surg Oncol; 2008 May; 15(5):1316-21. PubMed ID: 18311507
[TBL] [Abstract][Full Text] [Related]
33. Added value of blue dye in sentinel node biopsy for breast cancer.
Snoj M; Golouh R; Movrin-Stanovnik T; Vidergar-Kralj B
J Exp Clin Cancer Res; 2003 Dec; 22(4):551-5. PubMed ID: 15053296
[TBL] [Abstract][Full Text] [Related]
34. Sentinel node biopsy in breast cancer patients treated with neoadjuvant chemotherapy.
Tanaka Y; Maeda H; Ogawa Y; Nishioka A; Itoh S; Kubota K; Ue H; Nakatani K; Sasaguri S
Oncol Rep; 2006 Apr; 15(4):927-31. PubMed ID: 16525681
[TBL] [Abstract][Full Text] [Related]
35. Can methylene blue only be used in sentinel lymph node biopsy for breast cancer?
Golshan M; Nakhlis F
Breast J; 2006; 12(5):428-30. PubMed ID: 16958960
[TBL] [Abstract][Full Text] [Related]
36. Minimal access breast surgery: a single breast incision for breast conservation surgery and sentinel lymph node biopsy.
Spillane AJ; Brennan ME
Eur J Surg Oncol; 2009 Apr; 35(4):380-6. PubMed ID: 18757165
[TBL] [Abstract][Full Text] [Related]
37. Sentinel lymph node mapping of breast cancer: a case-control study of methylene blue tracer compared to isosulfan blue.
Eldrageely K; Vargas MP; Khalkhali I; Venegas R; Burla M; Gonzalez KD; Vargas HI
Am Surg; 2004 Oct; 70(10):872-5. PubMed ID: 15529840
[TBL] [Abstract][Full Text] [Related]
38. Methylene blue dye--a safe and effective alternative for sentinel lymph node localization.
Varghese P; Abdel-Rahman AT; Akberali S; Mostafa A; Gattuso JM; Carpenter R
Breast J; 2008; 14(1):61-7. PubMed ID: 18186867
[TBL] [Abstract][Full Text] [Related]
39. Prospective comparison of peritumoral and subareolar injection of blue dye alone, for identification of sentinel lymph nodes in patients with early stage breast cancer.
Kaklamanos IG; Birbas K; Syrigos K; Bonatsos VG; Bonatsos G
J Surg Oncol; 2011 Jul; 104(1):37-40. PubMed ID: 21360537
[TBL] [Abstract][Full Text] [Related]
40. Safety and technical success of methylene blue dye for lymphatic mapping in breast cancer.
Zakaria S; Hoskin TL; Degnim AC
Am J Surg; 2008 Aug; 196(2):228-33. PubMed ID: 18367146
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
